GLENMARK PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 30.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 30.1%
Mon, 13 Aug

GLENMARK PHARMA has announced its results for the quarter ended June 2018. Here is a detailed performance review of the same:

GLENMARK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-17*
3
Mar-18*
3
Jun-18*
QoQ ChangeYoY Change
Net SalesRs m23,63022,79821,656-5.0%-8.4%
Other incomeRs m1536961,38298.7%804.1%
TurnoverRs m23,78323,49423,038-1.9%-3.1%
ExpensesRs m17,85619,53018,187-6.9%1.9%
Gross profitRs m5,7743,2683,4696.1%-39.9%
DepreciationRs m7777357948.0%2.1%
InterestRs m7097447906.2%11.5%
Profit before taxRs m4,4412,4853,26731.5%-26.4%
TaxRs m1,108968937-3.2%-15.4%
Profit after taxRs m3,3341,5162,33053.7%-30.1%
Gross profit margin%24.414.316.0
Effective tax rate%24.939.028.7
Net profit margin%14.06.510.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 8.4% on a year-on-year (YoY) basis. The expenses were up by 1.9% YoY during the same period.
  • The company's operating profit declined by 39.9% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 16.0% in 1QFY19 as against 24.4% in 1QFY18.
  • Depreciation charges and finance costs increased by 2.1% YoY and 11.5% YoY, respectively.
  • Other income increased by 804.1% YoY during the quarter.
  • Net profit for the quarter declined by 30.1% YoY. Net profit margins during the quarter declined from 14.0% in 1QFY18 to 10.1% in 1QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 5.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 6.9% QoQ during the same period.
  • The company's operating profit increased by 6.1% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 16.0% in 1QFY19 as against 14.3% in 4QFY18.
  • Net profit for the quarter increased by 53.7% QoQ, while net profit margins increased from 6.5% in 4QFY18 to 10.1% in 1QFY19.

To see how GLENMARK PHARMA has performed over the last eight quarters, please visit here.

GLENMARK PHARMA Share Price Performance

Over the last one year, GLENMARK PHARMA share price has moved up from Rs 616.9 to Rs 584.7, registering a Loss of Rs 32.3 or around 5.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,339.6 (up 0.6%). Over the last one year it has moved up from 12,807.8 to 14,339.6, a gain of 1,532 points (up 12.0%).

Overall, the S&P BSE SENSEX is up 19.5% over the year.

Current Valuations

At the current price of Rs 584.7, the price to earnings (P/E) ratio of GLENMARK PHARMA stands at 22.5 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.5 times.

Equitymaster requests your view! Post a comment on "GLENMARK PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 30.1%". Click here!

  

Related Views on News

GLENMARK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of GLENMARK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

GLENMARK PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 53.1% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, GLENMARK PHARMA has posted a net profit of Rs 1 bn (down 53.1% YoY). Sales on the other hand came in at Rs 23 bn (up 7.3% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 6.6% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, GLENMARK PHARMA has posted a net profit of Rs 2 bn (up 6.6% YoY). Sales on the other hand came in at Rs 26 bn (up 12.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

GLENMARK PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of GLENMARK PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of GLENMARK PHARMA. Also includes updates on the valuation of GLENMARK PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

GLENMARK PHARMA SHARE PRICE


Jan 21, 2020 (Close)

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - ACTAVIS COMPARISON

COMPARE GLENMARK PHARMA WITH

MARKET STATS